(Q37230186)

English

Cyclin D1 overexpression, p16 loss, and pRb inactivation play a key role in pulmonary carcinogenesis and have a prognostic implication for the long-term survival in non-small cell lung carcinoma patients

scientific article published on 30 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Cyclin D1 overexpression, p16 loss, and pRb inactivation play a key role in pulmonary carcinogenesis and have a prognostic implication for the long-term survival in non-small cell lung carcinoma patients (English)

1 reference

Europe PubMed Central

19 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Na-Hye Myong

1

1 reference

Europe PubMed Central

19 August 2017

publication date

30 June 2008

1 reference

Europe PubMed Central

19 August 2017

Cancer Research and Treatment

1 reference

Europe PubMed Central

19 August 2017

40

1 reference

Europe PubMed Central

19 August 2017

2

1 reference

Europe PubMed Central

19 August 2017

45-52

1 reference

Europe PubMed Central

19 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

30 June 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

Analysis of cell cycle regulator proteins in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

Cancer cell cycles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

9 September 2017

Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

28 September 2017

Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

26 June 2018

Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

3 September 2018

Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

3 September 2018

The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

3 September 2018

Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

3 September 2018

Rb and p16INK4a expression in resected non-small cell lung tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697490

3 September 2018

Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

G1 control gene status is frequently altered in resectable non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis for G1 cell-cycle regulators: useful for predicting course of disease and for assessment of therapy in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4143/CRT.2008.40.2.45

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37230186&oldid=2164247266"